http://gensight-biologics.com/index.php?mact=News1,cntnt01,detail,0&cntnt01item_id=8&cntnt01returnid=37
GenSight Biologics Enrolls First Patient in Pivotal Phase III Program of GS010 in Leber’s Hereditary Optic Neuropathy
February 29, 2016

Archives
Categories
- Events (3)
- News (78)
- Press releases (84)
RECENT POSTS
February 28, 2023
February 20, 2023
